FDA Inspection
University Of Virginia Health SystemUniversity Of Virginia Health System – FDA Inspection, Mar 15, 2012
Record Details
This FDA Inspection record concerns University Of Virginia Health System, with an inspection on March 15, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- March 15, 2012
- Product Type
- Biologics
View Company Profile
ID · df61b00c-965d-421f-a58a-6da8f7734e39
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 774771
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
3- 21 CFR 606.100(c)Thorough investigations
- 21 CFR 606.160(a)(1)Concurrent documentation
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of University Of Virginia Health System
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 12, 2026 | VAI | Baltimore District Office | Blood and Blood Products |
| September 12, 2024 | VAI | Baltimore District Office | Blood and Blood Products |
| May 13, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| April 26, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 23, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for University Of Virginia Health System
- FDA Inspection 1321822 - 2026-06-12
- FDA Inspection 1249455 - 2024-09-12
- FDA Inspection 1170707 - 2022-05-13
- FDA Inspection 1094453 - 2019-04-26
- FDA Inspection 1020992 - 2017-06-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.